SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-005077
Filing Date
2021-12-08
Accepted
2021-12-08 08:34:54
Documents
13
Period of Report
2021-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-20211206.htm   iXBRL 8-K 57590
2 EX-99.1 bdsx-ex99_1.htm EX-99.1 13957
  Complete submission text file 0000950170-21-005077.txt   205368

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsx-20211206.xsd EX-101.SCH 2480
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsx-20211206_lab.xml EX-101.LAB 18489
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsx-20211206_pre.xml EX-101.PRE 11494
6 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20211206_htm.xml XML 4881
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 211477717
SIC: 8071 Services-Medical Laboratories